MX2021000327A - Enzimas de variante de fosforilasa de nucleosido de purina modificadas geneticamente. - Google Patents

Enzimas de variante de fosforilasa de nucleosido de purina modificadas geneticamente.

Info

Publication number
MX2021000327A
MX2021000327A MX2021000327A MX2021000327A MX2021000327A MX 2021000327 A MX2021000327 A MX 2021000327A MX 2021000327 A MX2021000327 A MX 2021000327A MX 2021000327 A MX2021000327 A MX 2021000327A MX 2021000327 A MX2021000327 A MX 2021000327A
Authority
MX
Mexico
Prior art keywords
enzymes
pnp
purine nucleoside
nucleoside phosphorylase
engineered
Prior art date
Application number
MX2021000327A
Other languages
English (en)
Inventor
Keith A Canada
Jeffrey C Moore
Vesna Mitchell
Nikki Dellas
Oscar Alvizo
Da Duan
Scott J Novick
Jovana Nazor
Mark Huffman
Deeptak Verma
Nicholas M Marshall
Jay Russell
Auric Anthony Sowell-Kantz
Granillo Agustina Rodriguez
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of MX2021000327A publication Critical patent/MX2021000327A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/02—Pentosyltransferases (2.4.2)
    • C12Y204/02001—Purine-nucleoside phosphorylase (2.4.2.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona enzimas de fosforilasa de nucleósido de purina (PNP) modificadas genéticamente, polipéptidos que tienen actividad de PNP y polinucleótidos que codifican estas enzimas, así como vectores y células hospederas que comprenden estos polinucleótidos y polipéptidos; también se proporcionan métodos para producir enzimas de PNP; la presente invención además proporciona composiciones que comprenden las enzimas de PNP y métodos para usar las enzimas de PNP modificadas genéticamente; la presente invención encuentra uso particular en la producción de compuestos farmacéuticos.
MX2021000327A 2018-07-09 2019-07-02 Enzimas de variante de fosforilasa de nucleosido de purina modificadas geneticamente. MX2021000327A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862695507P 2018-07-09 2018-07-09
US201962822263P 2019-03-22 2019-03-22
PCT/US2019/040359 WO2020014047A1 (en) 2018-07-09 2019-07-02 Engineered purine nucleoside phosphorylase variant enzymes

Publications (1)

Publication Number Publication Date
MX2021000327A true MX2021000327A (es) 2021-03-25

Family

ID=69102529

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021000327A MX2021000327A (es) 2018-07-09 2019-07-02 Enzimas de variante de fosforilasa de nucleosido de purina modificadas geneticamente.

Country Status (11)

Country Link
US (2) US11162105B2 (es)
EP (1) EP3820502A4 (es)
JP (2) JP7461658B2 (es)
KR (1) KR20210031926A (es)
CN (1) CN112601543A (es)
AU (1) AU2019302423A1 (es)
CA (1) CA3103718A1 (es)
IL (1) IL279886A (es)
MX (1) MX2021000327A (es)
SG (1) SG11202012111UA (es)
WO (1) WO2020014047A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112996511B (zh) * 2018-07-09 2024-08-09 默沙东有限责任公司 4’-乙炔基核苷类似物的酶促合成
KR20210031926A (ko) 2018-07-09 2021-03-23 코덱시스, 인코포레이티드 조작된 퓨린 뉴클레오사이드 포스포릴라제 변이체 효소
SG11202107145SA (en) 2019-01-25 2021-08-30 Univ Brown Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders
CN111534493B (zh) * 2020-04-01 2022-03-29 浙江大学宁波理工学院 一种嘌呤核苷磷酸化酶突变体、基因及应用
CN112980906B (zh) * 2021-04-14 2021-07-30 深圳瑞德林生物技术有限公司 一种用于制备β-烟酰胺单核苷酸的酶组合物及其应用
CN112795606B (zh) * 2021-04-14 2021-07-27 深圳瑞德林生物技术有限公司 一种β-烟酰胺单核苷酸的酶催化合成方法
CN114106063B (zh) * 2021-12-13 2023-04-07 福建瑞博奥科技有限公司 一种抗hiv病毒药物依曲拉韦的制备方法
CN116855471B (zh) * 2023-09-04 2023-11-28 江苏申基生物科技有限公司 一种嘌呤核苷磷酸化酶突变体及其应用

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6491905B1 (en) 1993-09-14 2002-12-10 The Uab Research Foundation Recombinant bacterial cells for delivery of PNP to tumor cells
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
CN1192108C (zh) 1994-06-03 2005-03-09 诺沃奇梅兹生物技术有限公司 纯化的毁丝霉属漆酶及编码该酶的核酸
ATE294871T1 (de) 1994-06-30 2005-05-15 Novozymes Biotech Inc Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
DK1717322T3 (da) 1997-01-17 2012-10-22 Codexis Mayflower Holdings Llc Udvikling af hele celler og organismer ved rekursiv sekvensrekombination
AU6029998A (en) 1997-01-17 1998-08-07 Regents Of The University Of Minnesota Dna molecules and protein displaying improved triazine compound degrading ability
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
EP1036198B1 (en) 1997-12-08 2012-09-26 California Institute Of Technology Method for creating polynucleotide and polypeptide sequences
IL138800A0 (en) 1998-04-02 2001-10-31 Tellus Genetic Resources Inc A method of identifying a plant with a lesion in a gene sequence
BR9910174A (pt) 1998-05-01 2001-03-06 Maxygen Inc Processo para se obter um gene recombinante otimizado de resistência à praga, biblioteca, e, processo para se obter um organismo que seja patogênico a uma praga de vegetal
EP1090024A2 (en) 1998-06-17 2001-04-11 Maxygen, Inc. Method for producing polynucleotides with desired properties
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
AU5347999A (en) 1998-08-12 2000-03-06 Maxygen, Inc. Dna shuffling of monooxygenase genes for production of industrial chemicals
JP2002526107A (ja) 1998-10-07 2002-08-20 マキシジェン， インコーポレイテッド マイコトキシンの解毒のための核酸を生成するためのｄｎａシャッフリング
EP1129184A1 (en) 1998-11-10 2001-09-05 Maxygen, Inc. Modified adp-glucose pyrophosphorylase for improvement and optimation of plant phenotypes
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7873477B1 (en) 2001-08-21 2011-01-18 Codexis Mayflower Holdings, Llc Method and system using systematically varied data libraries
US20070065838A1 (en) 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
AU3210100A (en) 1999-01-19 2000-08-01 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US8457903B1 (en) 1999-01-19 2013-06-04 Codexis Mayflower Holdings, Llc Method and/or apparatus for determining codons
IL144657A0 (en) 1999-02-11 2002-06-30 Maxygen Inc High throughput mass spectrometry
CA2364997A1 (en) 1999-03-05 2000-09-08 Maxygen, Inc. Encryption of traits using split gene sequences
US6703240B1 (en) 1999-04-13 2004-03-09 Maxygar, Inc. Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
CA2382462A1 (en) 1999-08-20 2001-03-01 Roche Diagnostics Gmbh Enzymatic synthesis of deoxyribonucleosides
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
US6686515B1 (en) 1999-11-23 2004-02-03 Maxygen, Inc. Homologous recombination in plants
SG121902A1 (en) 2000-01-11 2006-05-26 Maxygen Inc Integrated systems for diversity generation and screening
WO2001075767A2 (en) 2000-03-30 2001-10-11 Maxygen, Inc. In silico cross-over site selection
JP2004508011A (ja) 2000-04-03 2004-03-18 マキシジェン，　インコーポレイテッド スブチリシン変異体
US7037718B2 (en) 2001-10-26 2006-05-02 Cornell Research Foundation, Inc. Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
DK2278509T3 (en) 2002-03-01 2014-12-15 Codexis Mayflower Holdings Llc Methods, systems and software for identification of functional biomolecules
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US7620500B2 (en) 2002-03-09 2009-11-17 Maxygen, Inc. Optimization of crossover points for directed evolution
DK2250595T3 (en) 2008-02-12 2017-09-04 Codexis Inc PROCEDURE FOR SELECTING AN OPTIMIZED VARIETY OF VARIETIES
US8768871B2 (en) 2008-02-12 2014-07-01 Codexis, Inc. Method of generating an optimized, diverse population of variants
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
WO2009152336A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
ES2609685T7 (es) 2008-08-15 2019-05-22 Uab Res Found Purina nucleósido fosforilasa como activador enzimático de profármacos de nucleósidos
HUE042817T2 (hu) 2011-06-28 2019-07-29 Codexis Inc Fehérjevariánsok elõállítása régiókeveréssel
US20150133698A1 (en) 2012-04-20 2015-05-14 Codexis, Inc. Production of fatty alcohols from engineered microorganisms
KR20210031926A (ko) 2018-07-09 2021-03-23 코덱시스, 인코포레이티드 조작된 퓨린 뉴클레오사이드 포스포릴라제 변이체 효소

Also Published As

Publication number Publication date
JP7461658B2 (ja) 2024-04-04
EP3820502A1 (en) 2021-05-19
KR20210031926A (ko) 2021-03-23
JP2023126615A (ja) 2023-09-07
US20200010834A1 (en) 2020-01-09
AU2019302423A1 (en) 2021-01-07
JP2021530979A (ja) 2021-11-18
CA3103718A1 (en) 2020-01-16
IL279886A (en) 2021-03-01
EP3820502A4 (en) 2022-07-20
US20220010316A1 (en) 2022-01-13
SG11202012111UA (en) 2021-01-28
CN112601543A (zh) 2021-04-02
WO2020014047A1 (en) 2020-01-16
US12110493B2 (en) 2024-10-08
US11162105B2 (en) 2021-11-02

Similar Documents

Publication Publication Date Title
MX2021000327A (es) Enzimas de variante de fosforilasa de nucleosido de purina modificadas geneticamente.
MX2021000328A (es) Enzimas de variantes de galactosa oxidasa modificadas geneticamente.
AU2017380488A8 (en) Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
MX2021000322A (es) Enzimas de variante fosfopentomutasa modificada geneticamente.
MX2020006117A (es) Integracion dirigida de acidos nucleicos.
MX2021000323A (es) Enzimas de variante de pantotenato quinasa modificadas geneticamente.
MX2023011785A (es) Metodos y composiciones para produccion de proteina de clara de huevo.
MX2023001119A (es) Variantes de enzimas y polinucleotidos que las codifican.
PH12014502767A1 (en) Interleukin-2 fusion proteins and uses thereof
MX2018004600A (es) Celulas aniquiladoras naturales y células ilc3 y usos de las mismas.
AU2018264463A1 (en) Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
MX2019000140A (es) Variantes de xilanasa y polinucleotidos que las codifican.
MX2021015614A (es) Enzimas variantes de sacarosa fosforilasa modificadas geneticamente.
MX2019014889A (es) Polipeptidos que tienen actividad trehalasa y polinucleotidos que los codifican.
MX2015000312A (es) Polipeptidos que tienen actividad lipasa y polinucleotidos que los codifican.
EP3929285A3 (en) Methods of reducing odor
PH12018502655A1 (en) Enzymatic glycosylation of steviol glycosides and other compounds with glucose-1-phosphate
WO2017103159A9 (en) Polypeptides having xylanase activity and polynucleotides encoding same
PH12018502656A1 (en) Engineered beta-glucosidases and glycosylation methods
AU2017384228A8 (en) Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
EP3988653A3 (en) Udp-glycosyltransferases from solanum lycopersicum
MX349517B (es) Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos.
MX2018014234A (es) Polipeptidos que tienen actividad alfa-galactosidasa y polinucleotidos que los codifican.
MX2018013875A (es) Composiciones que comprenden polipeptidos que tienen actividad galactanasa y polipeptidos que tienen actividad beta-galactosidasa.
TW200734350A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same